| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | KUW1QG1ZM3 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | T-cell surface antigen CD2 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 2 | D011565 | ClinicalTrials |
| Kidney Failure, Chronic | 2 | D007676 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Renal Insufficiency, Chronic | 1 | D051436 | ClinicalTrials |
| Graft vs Host Disease | 1 | D006086 | ClinicalTrials |
| Renal Insufficiency | 1 | D051437 | ClinicalTrials |
| Lymphoproliferative Disorders | 1 | D008232 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 1 | D003922 | ClinicalTrials |
| Hidradenitis Suppurativa | 1 | D017497 | ClinicalTrials |
| Anemia, Sickle Cell | 1 | D000755 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108742 |
| FDA SRS | KUW1QG1ZM3 |
CONTENTS